The extract of Ginkgo biloba (EGB) inhibits survivin gene expression in ACC-2 cells, induces apoptosis, and suppresses tumor cell proliferation, suggesting its potential as a therapeutic target [56]. Here, BIRC5 is linked to neoplasm.